Qizhu Yuling prescription in the prevention of postoperative metastasis and recurrence of esophagus cancer: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial

Qizhu Yuling prescription in the prevention of postoperative metastasis and recurrence of esophagus cancer: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial

BackgroundEsophageal cancer (EC) is a malignant tumor with a high recurrence and metastasis rate and poor prognosis. In 2024, China ranked first in the world in terms of new EC cases and deaths. Surgery is the main treatment method for EC, but the clinical difficulty is how to prevent recurrence and...

Full description

Saved in:
Bibliographic Details
Main Authors: Miao Kong, Bowen Xu, Guanghui Zhu, Xinmiao Wang, Ziyu Kuang, Qianhui Sun, Kexin Liu, Zilin Wang, Ying Zhang, Jie Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Oncology
Subjects:
Qizhu Yuling prescription
esophageal cancer
traditional Chinese medicine
randomized controlled trial
disease-free survival
protocol
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1478390/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1478390/full

Similar Items